Groups
Company Size (Fulltime employees)
Looking for
Functionality
Headquartner in China
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Medtech Category
Medtech Development Stage
Index
Countries
Reset

able cerebral United States

Able Cerebral is currently apply phase III clinical study with FDA for its controlled release of brain energy product. The product has shown remarkable therapeutic effectiveness for mid-stage and early stage Alzheimer's disease.

Able Cerebral is also developing a game changing, non-invasive medical device that will consolidate and recovery of brain memory for mid-stage and late stage Alzheimer's disease.

Website:
www.ablecerebral.com
Year of foundation
2012
Looking for
Funding Status
looking for investors or partners for advance our product and programs. Able Cerebral is ready to convert to Delaware C-Corp
Headquartner in China
No
Plan in China
We were planning to engage some sci-tech park in China before the pandemic.
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Medtech Category
Medtech Development Stage
Slides Deck
(pptx, 308.49KB)
jun xia
Co-Founder / President 
Functionality
Management

BioValleyCHINA Ventures United States

Assist Consultation, Assistance, Service
• Identify Distribution Opportunities, Partners, Joint Ventures
• Guidance for Product Registration (SFDA), Regulatory Issues
• Intellectual Property Assessment
• Develop Successful Business Strategy
• Marketing/Analysis
• Manufacturing/Sourcing
• Investment Advisory
Website:
www.paulderiddermd.com
Company Size (Fulltime employees)
1-10
Year of foundation
2007
Looking for
Funding Status
self
Headquartner in China
No
Plan in China
Bring US based biomedical technology into China markets
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Medtech Category
Medtech Development Stage
Paul DeRidder
President 
Functionality
Business Development

Carmel Diagnostics ltd. Israel

Carmel Diagnostics is a medtech company who developed an innovative method for measuring Oxidative Stress (OS) of a biological liquid, a recognized biomarker of health and disease and a key diagnostics parameter. This OS parameter is measured by TCL (ThermoChemiLuminescence), an advanced yet simple technology. Carmel’s lead product is Embryo Selection in IVF process. Carmel won the prestigious Phase-2 grant from Horizon2020, planning market launch in H1/2021. It has an experienced, motivated team.

Website:
Carmel Diagnostics ltd.
Company Size (Fulltime employees)
1-10
Year of foundation
2009
Looking for
Please specify your partnering goal
Potential licensing
Funding Status
Series A, looking for an investment of 4M USD
Now raising (In USD)
5M
Headquartner in China
No
Plan in China
We have already registered WFOE in China. Our plans are:Establish Manufacturing site and customer support in ChinaFertissimo distribution in China to improve IVF performancePromote Additional applications in cooperation with Chinese Institutes/Academy/IndustryPromote the use of AI, Bioinformatics and machine learning for optimization and continuous improvement
Medtech Category
Medtech Information 1, Device Name|Description|Development Stage|Licensed Countries
Fertissimo TCL Analyzer. CE Mark
Medtech Development Stage
Slides Deck
(pptx, 7.32MB)
Mr Tzali Cnaani
LinkedIn logo CEO 
Functionality
Management

Consulate General of Canada in Shanghai China

For more than 120 years, the Trade Commissioner Service (TCS) has been helping Canadian companies navigate international markets. Our trade commissioners in more than 160 cities worldwide can provide you with key business insights and access to an unbeatable network of international contacts. The TCS provides Canadian businesses and organizations with tailored advice to help them enter new markets outside of Canada.
Website:
https://www.tradecommissioner.gc.ca/about-a_propos/index.aspx?lang=eng
Year of foundation
1895
Looking for
Please specify your partnering goal
To expand Canadian life science innovation organizations and companies' access to China opporutnity and partnerships.
Headquartner in China
No
Plan in China
To promote and support above Canadian community's China IBD and partnership efforts and strategy on a sustainable basis.
Biotech/Pharma Category
Medtech Category
Lulu Mi
Life Sciences Trade Commissioner 
Functionality
Business Development

IHM-GBA China

Based in Guanghzou, China, IHM-GBA is an innovation center focusing on high performance medical device. We are seeking global opportunities of bringing disruptive technologies to the Chinese market. We invest in and partner with startups that are interested in exploring China and use our resources to commercialize their products.

Website:
www.ihm-gba.com
Year of foundation
2019
Looking for
Please specify your partnering goal
investment/partnership/license
Headquartner in China
Yes
Medtech Category
Investment Focus
Medical device
Mr shu zeng
Director 
Functionality
Business Development

MAVIE Technologies China

Investment banking boutique specialized in cross-border medical device transactions.
We would like to bring to your next events exclusive opportunities from Western companies in the fields of: robotics, cancer screening, liver disease diagnostic, robotics, cardiovascular and respiratory
Website:
www.mavietech.com
Company Size (Fulltime employees)
1-10
Year of foundation
2016
Looking for
Headquartner in China
Yes
Medtech Category
Olivier D ARROS
Managing Partner 
Functionality
Management

MedWorld Advisors United States

MedWorld Advisors is an international M&A Services Firm. We represent medical technology companies from the US, EU and Israel that want to enter the China market. We facilitate licensing, commercialization and acquisition deals between our clients and larger companies / investors in China. We are based in Boston in the U.S. We also have an operation in Hong Kong to help facilitate deals, as helpful.
Website:
www.medworldadvisors.com
Company Size (Fulltime employees)
1-10
Year of foundation
2015
Looking for
Please specify your partnering goal
We currently have 10 Medical Technology projects that may be interesting for the China market. We seek to meet appropriate China partners for these projects.
Headquartner in China
No
Plan in China
We have projects in medical imaging, image processing, endoscopy, endo-vascular, hemodynamics, oximetry, digital health, wearables, and wound care that may be interesting for the China market.
Medtech Category
Medtech Information 1, Device Name|Description|Development Stage|Licensed Countries
Multiple Projects|Open for Licensing / Acquisition|FDA Cleared|US, EU and Israel
Medtech Development Stage
Dave Sheppard
Managing Director 
Functionality
Business Development